High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression

Journal of Child Neurology

Volumn 21, Issue 6, 2006, Pages 444-449

  Sokol, Deborah K ^a   Chen, Demao ^a   Farlow, Martin R ^a   Dunn, David W ^a   Maloney, Bryan ^a   Zimmer, Jennifer A ^a   Lahiri, Debomoy K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA SECRETASE; AMPHETAMINE; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; ARIPIPRAZOLE; CARBAMAZEPINE; CLONIDINE; OLANZAPINE; PHENOBARBITAL; PHENYTOIN; PROPRANOLOL; RISPERIDONE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; AGE DISTRIBUTION; AGGRESSION; ALZHEIMER DISEASE; ARTICLE; AUTISM; BRAIN DEVELOPMENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RATING SCALE; SEIZURE;

ACETYLCHOLINESTERASE; ADOLESCENT; AGGRESSION; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PEPTIDE FRAGMENTS; SEVERITY OF ILLNESS INDEX;

EID: 33746049824     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.2310/7010.2006.00130     Document Type: Article

References (24)

1. Sokol DK, Edwards-Brown M: Neuroimaging in autistic spectrum disorder (ASD). J Neuroimaging 2004;14:8-15.
2. Courchesne E, Karns CM, Davis HR, et al: Unusual brain growth patterns in early life in patients with autistic disorder. Neurology 2001;57:245-254.
3. Aylward EH, Minshew NJ, Field K, et al: Effects of age on brain volume and head circumference in autism. Neurology 2002;59:175-183.
4. Perry EK, Lee ML, Martin-Ruiz CM, et al: Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 2001;156:1058-1066.
5. Perry EK, Perry RH: Neurochemistry of consciousness: Cholinergic pathologies in the human brain. Prog Brain Res 2004;145:287-299.
6. Nelson KB, Grether JK, Croen LA, et al: Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001;57:245-254.
7. Bauman ML, Kemper TL: Neuro-anatomic observations of the brain in autism, in Bauman ML, Kemper TL (eds): The Neurobiology of Autism. Baltimore, Johns Hopkins University Press, 1994, 119-145.
8. Martin-Ruiz CM, Lee M, Perry PH, et al: Molecular analysis of nicotinic receptor expression of autism. Brain Res Mol Brain Res 2004;123:81-90.
9. Lee M, Martin-Ruiz C, Graham A, et al: Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002;125: 1483-1495.
10. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002;297:353-356.
11. Lahiri DK, Farlow MR, Sambamurti K, et al: A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr Drug Targets 2003;4:97-112.
12. Ge YW, Lahiri DK: Regulation of promoter activity of the APP gene by cytokines and growth factors: Implications in Alzheimers disease. Ann N Y Acad Sci 2002;973:463-467.
13. Filipek PA: Autistic spectrum disorders, in Swaiman KF, Ashwal S (eds): Pediatric Neurology. St. Louis, Mosby, 1999, 606-628.
14. Deutsch SI, Rosse RB, Mastropaolo J, Chilton M: Progressive worsening of adaptive functions in Down syndrome may be mediated by the complexing of soluble a[beta] peptides with the [alpha]7 nicotinic acetylcholine receptor: Therapeutic implications. Clin Neuropharmacol 2003;26:277-283.
15. Sokol DK, Dunn DW, Edwards-Brown M, Feinberg J: Hydrogen proton magnetic resonance spectroscopy in autism: Preliminary evidence of elevated choline/creatine ratio. J Child Neurol 2002;17:245-249.
16. Schopler E, Reichler RR, Renner BR: Childhood Autism Rating Scale (CARS). Los Angeles, Western Psychological Services, 1988.
17. Lahiri DK, Chen D, Ge YW, et al: Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. J Pineal Res 2004;36:224-231.
18. Belcher JD, Bryant CJ, Nguyen J, et al: Transgenic sickle mice have vascular inflammation. Blood 2003;101:3953-3959.
19. Jyonouchi H, Sun S, Le H: Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001;120:170-179.
20. Zhang X: Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 2004;3:137-152.
21. Moore GJ: Proton magnetic resonance spectroscopy in pediatric neuroradiology. Pediatr Radiol 1998;28:805-814.
22. Esler WP, Wolfe MS: A portrait of Alzheimer secretases - New features and familiar faces. Science 2001;293:1449-1454.
23. Li Y, Hollingworth P, Moore P, et al: Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease. Hum Mutat 2005;25:270-277.
24. Sutcliffe JS, Han MK, Amin T, et al: Partial duplication of the APBA2 gene in chromosome 15q13 corresponds to duplicon structures. MC Genomics 2003;4(1):15.